igeahub.com
Investigational Ebola Vaccine Regimen Induced Durable Immune Response 1 Year After Vaccination in Phase 1 Study, Reported by Johnson & Johnson - IgeaHub
March 14, 2017 Johnson & Johnson announced that final Phase 1 clinical trial data published in JAMA: The Journal of the American Medical Association